Table IV.
Cluster | ID | Description | P-value | Adjusted P-value | Gene ID |
---|---|---|---|---|---|
let-7j | mmu00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 2.85×103 | 4.75×102 | B3gnt5, Fut9 |
let-7j | mmu00512 | Mucin type O-glycan biosynthesis | 3.06×103 | 4.75×102 | Galnt2, Galnt12 |
miR-181c-5p | mmu00250 | Alanine, aspartate and glutamate metabolism | 1.37×102 | 4.53×102 | Gfpt1 |
miR-181c-5p | mmu00520 | Amino sugar and nucleotide sugar metabolism | 1.81×102 | 4.53×102 | Gfpt1 |
miR-181d-5p | mmu00250 | Alanine, aspartate and glutamate metabolism | 1.37×102 | 4.53×102 | Gfpt1 |
miR-181d-5p | mmu00520 | Amino sugar and nucleotide sugar metabolism | 1.81×102 | 4.53×102 | Gfpt1 |
let-7g-5p | mmu04550 | Signaling pathways regulating pluripotency of stem cells | 6.84×105 | 6.57×103 | Smarcad1, Skil, Wnt16, Hand1, Hoxb1, Acvr1c |
let-7g-5p | mmu00280 | Valine, leucine and isoleucine degradation | 1.92×104 | 9.22×103 | Agxt2, Bcat1, Ehhadh, Acat1 |
let-7c-5p | mmu04550 | Signaling pathways regulating pluripotency of stem cells | 5.95×105 | 5.59×103 | Smarcad1, Skil, Wnt16, Hand1, Hoxb1, Acvr1c |
miR-222-3p | mmu04727 | GABAergic synapse | 6.35×104 | 2.35×102 | Gng5, Gabra1, Gnb3 |
miR-222-3p | mmu05032 | Morphine addiction | 7.23×104 | 2.35×102 | Gng5, Gabra1, Gnb3 |
miR-222-3p | mmu04724 | Glutamatergic synapse | 1.35×103 | 2.92×102 | Gng5, Ppp3r1, Gnb3 |
miR-222-3p | mmu04371 | Apelin signaling pathway | 2.38×103 | 3.85×102 | Agtr1a, Gng5, Gnb3 |
miR-222-3p | mmu04723 | Retrograde endocannabinoid signaling | 2.96×103 | 3.85×102 | Gng5, Gabra1, Gnb3 |
miR-222-3p | mmu04151 | PI3K-Akt signaling pathway | 4.02×103 | 4.36×102 | Ddit4, Gng5, Gnb3, Kit |
miR-10b-3p | mmu05144 | Malaria | 6.08×103 | 2.68×102 | Ccl12 |
miR-10b-3p | mmu05323 | Rheumatoid arthritis | 1.03×102 | 2.68×102 | Ccl12 |
miR-10b-3p | mmu04657 | IL-17 signaling pathway | 1.13×102 | 2.68×1024 | Ccl12 |
miR-10b-3p | mmu04933 | AGE-RAGE signaling pathway in diabetic complications | 1.24×102 | 2.68×102 | Ccl12 |
miR-10b-3p | mmu05142 | Chagas disease (American trypanosomiasis) | 1.26×102 | 2.68×102 | Ccl12 |
miR-10b-3p | mmu04668 | TNF signaling pathway | 1.34×102 | 2.68×102 | Ccl12 |
miR-10b-3p | mmu05418 | Fluid shear stress and atherosclerosis | 1.76×102 | 2.78×102 | Ccl12 |
miR-10b-3p | mmu04621 | NOD-like receptor signaling pathway | 2.08×102 | 2.78×102 | Ccl12 |
miR-10b-3p | mmu05164 | Influenza A | 2.08×102 | 2.78×102 | Ccl12 |
miR-10b-3p | mmu04062 | Chemokine signaling pathway | 2.42×102 | 2.90×102 | Ccl12 |
miR-10b-3p | mmu05168 | Herpes simplex infection | 2.67×102 | 2.91×102 | Ccl12 |
miR-10b-3p | mmu04060 | Cytokine-cytokine receptor interaction | 3.36×102 | 3.36×102 | Ccl12 |
miR-8112 | mmu04150 | mTOR signaling pathway | 1.40×102 | 8.55×104 | Fzd8, Clip1, Wnt9b, Wnt3a, Wnt2b, Lpin1 |
miR-8112 | mmu05217 | Basal cell carcinoma | 4.06×105 | 1.24×103 | Fzd8, Wnt9b, Wnt3a, Wnt2b |
miR-8112 | mmu04916 | Melanogenesis | 4.17×104 | 8.48×103 | Fzd8, Wnt9b, Wnt3a, Wnt2b |
miR-8112 | mmu04550 | Signaling pathways regulating pluripotency of stem cells | 1.36×103 | 1.60×102 | Fzd8, Wnt9b, Wnt3a, Wnt2b |
miR-8112 | mmu05224 | Breast cancer | 1.64×103 | 1.60×102 | Fzd8, Wnt9b, Wnt3a, Wnt2b |
miR-8112 | mmu04310 | Wnt signaling pathway | 1.72×103 | 1.60×102 | Fzd8, Wnt9b, Wnt3a, Wnt2b |
miR-8112 | mmu04390 | Hippo signaling pathway | 2.10×103 | 1.60×102 | Fzd8, Wnt9b, Wnt3a, Wnt2b |
miR-8112 | mmu00532 | Glycosaminoglycan biosynthesis - chondroitin sulfate/dermatan sulfate | 2.28×103 | 1.60×102 | Chst15, B3galt6 |
miR-8112 | mmu05200 | Pathways in cancer | 2.36×103 | 1.60×102 | Fzd8, Wnt9b, Lpar1, Wnt3a, Wnt2b, Bcr |
miR-8112 | mmu04974 | Protein digestion and absorption | 3.98×103 | 2.43×102 | Col2a1, Atp1a2, Col11a1 |
miR-8112 | mmu05205 | Proteoglycans in cancer | 5.96×103 | 3.30×102 | Fzd8; Wnt9b, Wnt3a, Wnt2b |
miR, microRNA; mmu, Mus musculus.